Biomimetic Brain-Targeted Delivery of Esterified XAV939 for Treating Autism-Associated Social Deficits

<b>Background/Objectives</b>: Autism spectrum disorder (ASD) is a group of developmental disorders featured by social dysfunction, for which there still lacks effective treatments. Our previous study demonstrated that XAV939, a tankyrase inhibitor, could alleviate social dysfunction in two ASD mouse...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hanze Liu, Ya-Rong Wang, Mengmeng Wang, Tiantian Yu, Daozhou Liu, Jing Wang, Yang Gao, Yuanyiyang Hu, Hongyu Ma, Feng Gao, Shengxi Wu, Zhao Wei, Yazhou Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2026-07-01
coleção:	Pharmaceutics
Assuntos:	autism spectrum disorder social deficits XAV939 biomimetic brain targeting
Acesso em linha:	https://www.mdpi.com/1999-4923/18/8/951
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!